Artículo original
¿Es el intervalo libre de docetaxel un factor predictivo para el cáncer de próstata resistente a la castración?
Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer?
S. Aya,
, Ö. Efiloğlub, D. Tataroğlu Özyükselerc, Ö. Dülgara, U. Mutlu Günaydına, A. Yıldırımb, M. Gümüşa
Autor para correspondencia
a Istanbul Medeniyet University Göztepe Education and Training Hospital, Medical Oncology Clinic, Kadıköy, İstanbul, Turquía
b Istanbul Medeniyet University Göztepe Education and Training Hospital, Urology Clinic, Kadıköy, İstanbul, Turquía
c Istanbul Kartal Lutfi Kirdar Education and Research Hospital, Medical Oncology Clinic, Kadıköy, İstanbul, Turquía
Leído
49
Vecesse ha leído el artículo
8
Total PDF
41
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 4 | 4 | 0 | 4 |
| 2024 3 | 1 | 0 | 1 |
| 2024 1 | 1 | 0 | 1 |
| 2023 4 | 1 | 0 | 1 |
| 2023 3 | 2 | 0 | 2 |
| 2023 2 | 1 | 0 | 1 |
| 2022 1 | 1 | 2 | 3 |
| 2022 12 | 3 | 2 | 5 |
| 2022 11 | 27 | 4 | 31 |
